Download PDF
Geburtshilfe Frauenheilkd 2015; 75(5): 428-431
DOI: 10.1055/s-0035-1545932
Aktuell diskutiert
Georg Thieme Verlag KG Stuttgart · New York

Reproduktionsmedizin. Risiken der Mitochondrien-Ersatztherapie in der Reproduktionsmedizin

Klaus Reinhardt
Further Information

Publication History

Publication Date:
09 June 2015 (online)

Also available at
    Permissions and Reprints

Die Mitochondrien-Ersatztherapie (MET) soll es Trägerinnen mitochondrial bedingter Mutationen ermöglichen, gesunde, aber genetisch „eigene“ Kinder zu bekommen. In Großbritannien wurde diese Methode Anfang dieses Jahres vom Parlament für die Klinik zugelassen. Und das obwohl in wissenschaftlichen Kreisen Risiken der MET diskutiert werden.

 

  • Literatur

  • 1 Gorman GS, Grady JP, Turnbull DM et al. Mitochondrial donation – how many women could benefit?. N Engl J Med 2015; 372: 885-887
    CrossrefPubMedGoogle Scholar
  • 2 Schaefer AM, McFarland R, Blakely EL et al. Prevalence of mitochondrial DNA disease in adults. Ann Neurol 2008; 63: 35-39
    CrossrefPubMedGoogle Scholar
  • 3 Schon EA, DiMauro S, Hirano M. Human mitochondrial DNA: roles of inherited and somatic mutations. Nat Rev Genet 2012; 13: 878-890
    CrossrefPubMedGoogle Scholar
  • 4 Dobler R, Rogell B, Budar F et al. A meta-analysis of the strength and nature of cytoplasmic genetic effects. J Evol Biol 2014; 27: 2021-2034
    CrossrefPubMedGoogle Scholar
  • 5 Morrow EH, Reinhardt K, Wolff JN et al. Risks inherent to mitochondrial replacement. EMBO Rep 2015; DOI: 10.15252/embr.201439110.
    PubMedGoogle Scholar
  • 6 van der Walt JM, Nicodemus KK, Martin ER et al. Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am J Hum Genet 2003; 72: 804-811
    CrossrefPubMedGoogle Scholar
  • 7 Luo L-F, Hou C-C, Yang W-X. Nuclear factors: roles related to mitochondrial deafness. Gene 2013; 520: 79-89
    CrossrefPubMedGoogle Scholar
  • 8 Chinnery PF, Craven L, Mitalipov S et al. The challenges of mitochondrial replacement. PLoS Genet 2014; 10: e1004315
    CrossrefPubMedGoogle Scholar
  • 9 Reinhardt K, Dowling DK, Morrow EH. Mitochondrial replacement, evolution, and the clinic. Science 2013; 341: 1345-1346
    CrossrefPubMedGoogle Scholar
  • 10 Burgstaller JP, Johnston IG, Jones NS et al. mtDNA segregation in heteroplasmic tissues is common in vivo and modulated by haplotype differences and developmental stage. Cell Rep 2014; 7: 2031-2041
    CrossrefPubMedGoogle Scholar
  • 11 Innocenti P, Morrow EH, Dowling DK. Experimental evidence supports a sex-specific selective sieve in mitochondrial genome evolution. Science 2011; 332: 845-848
    CrossrefPubMedGoogle Scholar
  • 12 St John JC, Campbell KH. The battle to prevent the transmission of mitochondrial DNA disease: is karyoplast transfer the answer?. Gene Ther 2010; 17: 147-149
    CrossrefPubMedGoogle Scholar
  • 13 The PLOS Genetics Staff. Correction: the challenges of mitochondrial replacement. PLoS Genet 2014; 10: e1004472
    CrossrefPubMedGoogle Scholar